A critical advance in cancer study is arising with the use of VHH fragments to restore dysfunctional p53. This essential cancer protector protein is frequently disabled in many kinds of tumors, resulting uncontrolled https://socialbuzzfeed.com/story7518747/mini-antibodies-revive-the-p53-protein-the-potential-hope-for-cancer-management